CD44 and CXCL9 serum protein levels predict the risk of clinically significant allograft rejection after liver transplantation

Knock-Down of CD44 Regulates Endothelial Cell Differentiation via NFκB-Mediated Chemokine Production

(2014) Berit Olofsson et al.   PLoS One

Twenty-Year Longitudinal Follow-Up After Orthotopic Liver Transplantation: A Single-Center Experience of 313 Consecutive Cases

(2013) W. N. Schoening et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion

(2013) Bastian Höchst et al.   JOURNAL OF HEPATOLOGY

Update in liver transplantation

(2012) Saleh A. Alqahtani   CURRENT OPINION IN GASTROENTEROLOGY

Intracellular IFN-γ and IL-2 expression monitoring as surrogate markers of the risk of acute rejection and personal drug response in de novo liver transplant recipients

(2012) O. Millán et al.   CYTOKINE

Intragraft transcriptome level of CXCL9 as biomarker of acute cellular rejection after liver transplantation

(2012) Tadafumi Asaoka et al.   JOURNAL OF SURGICAL RESEARCH

The holy grail: a biomarker for acute rejection in liver transplantation

(2012) Michael W. Morris et al.   JOURNAL OF SURGICAL RESEARCH

Review article: Use of induction therapy in liver transplantation

(2012) Lionel Rostaing et al.   Transplantation Reviews

Predictors of long-term outcome after liver transplant

(2011) Michelle Rook et al.   Current Opinion in Organ Transplantation

Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: A proteomic signature validated by enzyme-linked immunosorbent assay

(2011) Omar Massoud et al.   LIVER TRANSPLANTATION

Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation

(2011) Waqar R. R. Farid et al.   LIVER TRANSPLANTATION

Serum cytokine profiles associated with early allograft dysfunction in patients undergoing liver transplantation

(2011) Benjamin H. Friedman et al.   LIVER TRANSPLANTATION

Pretransplant Serum CXCL9 and CXCL10 Levels Fail to Predict Acute Rejection in Kidney Transplant Recipients Receiving Induction Therapy

(2011) Sebastiaan Heidt et al.   TRANSPLANTATION

Biomarkers in solid organ transplantation: establishing personalized transplantation medicine

(2011) Silke Roedder et al.   Genome Medicine

Pre-transplant serum level of CXCL9 as a biomarker of acute rejection and graft failure risk in kidney transplantation

(2010) Sophie Brouard et al.   TRANSPLANT INTERNATIONAL

Chemokines and Their Receptors in Human Renal Allotransplantation

(2010) Denise J. Lo et al.   TRANSPLANTATION

Differentially Expressed RNA from Public Microarray Data Identifies Serum Protein Biomarkers for Cross-Organ Transplant Rejection and Other Conditions

(2010) Rong Chen et al.   PLoS Computational Biology

CXCR3, Inflammation, and Autoimmune Diseases

(2009) Stéphanie Lacotte et al.   Annals of the New York Academy of Sciences

Unique Aspects of Rejection and Tolerance in Liver Transplantation

(2009) Stuart Knechtle et al.   SEMINARS IN LIVER DISEASE

High pretransplant serum levels of CXCL9 are associated with increased risk of acute rejection and graft failure in kidney graft recipients

(2009) Mario Rotondi et al.   TRANSPLANT INTERNATIONAL